Orthovisc Vs. Supartz – Which Does What?

Hyaluronic acid injections are commonly used to manage knee osteoarthritis when conservative treatments do not provide sufficient symptom relief. Comparing Orthovisc vs Supartz can help healthcare providers understand differences in formulation, injection schedules, clinical use, and other practical considerations when selecting a viscosupplement.

Orthovisc and Supartz are two such treatments, known as viscosupplements. They mimic the physical properties of healthy human synovial fluid, providing cushioning and lubrication to the affected knee joint. Though they have similar effects, there are distinct differences between the two injections. 

In this article, we will compare Orthovisc and Supartz in detail and discuss their effectiveness, treatment regimen, and composition. 

Key Takeaways

• Orthovisc and Supartz are both hyaluronic acid injections used to treat knee osteoarthritis.
• Orthovisc and Supartz have different formulations and mechanisms of action.
• Clinical trials have shown that both treatments effectively reduce pain and improve function in patients with knee osteoarthritis.
• Safety profiles and patient satisfaction are essential when choosing between Orthovisc and Supartz.
• Administration protocols and cost are practical considerations that may influence treatment decisions.

Orthovisc vs Supartz: Understanding Both Treatments

Orthovisc is a treatment where doctors inject particular medicine into the knee. This medicine, called hyaluronic acid, helps knees move smoothly. It works like oil in an engine, letting your knee bend and straighten quickly.

Supartz is a treatment for knee pain caused by osteoarthritis. It uses a clear liquid called sodium hyaluronate, which doctors inject into the knee joint to make the knee move smoother. Below is a more detailed overview of both treatments.

Aspect	Orthovisc	Supartz
Chemical Composition	Composed of a different formulation	Highly purified sodium hyaluronate
Solution Characteristics	Unique formulation tailored for viscoelasticity	Designed for elasticity and viscosity similar to natural synovial fluid
Source Material	Is derived from bacterial fermentation and is non-animal-based.	Extracted and purified from rooster combs
Injection Frequency	Typically administered in a series of 3-4 injections	It may require up to 5 injections, depending on the patient’s response
Indications	Specifically approved for knee osteoarthritis	Also approved for knee osteoarthritis, with broader applications under investigation

Mechanism of Action

When comparing Orthovisc vs Supartz, both treatments aim to supplement synovial fluid and improve lubrication within the osteoarthritic knee, although their formulations and treatment protocols differ.

This side-by-side analysis underscores the unique approaches of Orthovisc and Supartz to managing knee osteoarthritis. Both aim to restore joint functionality and alleviate pain, yet they do so through slightly different pathways and with distinct focuses. Their effectiveness and the patient’s response can vary, underscoring the importance of a personalized treatment plan.

Aspect	Orthovisc	Supartz
Mechanism of Action	Orthovisc provides viscosupplementation, injecting hyaluronic acid directly into the knee joint. This boosts the joint’s lubricating and shock-absorbing properties.	Supartz improves joint lubrication through viscosupplementation and potentially enhances the viscoelastic properties of synovial fluid, offering dual-action relief.
Biomechanical Effects	It improves joint mobility by restoring the natural balance of hyaluronic acid in the joint, reducing friction and wear.	It enhances the viscoelasticity and lubrication of the synovial fluid, aiming to protect the cartilage and reduce joint pain more effectively.
Clinical Focus	Mainly targets symptom relief through direct supplementation of hyaluronic acid, addressing the loss of lubrication and cushioning in osteoarthritic knees.	Addresses symptom relief by improving biomechanical properties and promoting a healthier joint environment, which may offer broader benefits for joint function.

Clinical Efficacy

Orthovisc is a high-molecular-weight injection approved by the FDA for knee osteoarthritis pain. It helps patients find relief from joint pain and improves mobility. This treatment excels in its ability to manage symptoms effectively.

Studies confirm that Supartz can significantly ease pain and improve joint function for knee osteoarthritis patients. Thanks to such evidence, many professionals now see it as a viable option for enhancing joint mobility and providing long-term symptom relief.

Treatment	Efficacy in Knee Osteoarthritis	Disease-Specific Costs	Risk of Adverse Events
Orthovisc	Proven safe and efficacious	Higher compared to Supartz/Hyalgan	Comparable to other hyaluronic acid products
Supartz	Practical in managing pain and improving function	Lower than Synvisc and Orthovisc	Lower risk compared to other products

When evaluating other viscosupplementation options, healthcare providers may also compare Orthovisc vs Synvisc based on formulation, dosing schedules, clinical evidence, and individual patient needs.

Safety Profiles and Patient Outcomes

Orthovisc is known for its reliable safety profile. Most people who get this treatment find the side effects mild and not lasting long. Orthovisc’s prescribing information makes it a safer choice for those needing more than one shot of sodium hyaluronate to help with knee pain from osteoarthritis.

• “I have had 3 cortisone injections, not much relief. The new doctor suggested ortho, so I did. After 2nd injection relief, I had a 3. The most pain relief I’ve ever felt. I’m 3 months out and can do more around my home, but I still cannot walk long distances; that’s alright. I need to be able to take care of myself. Knee replacement surgery will be the only thing for long-term relief, I’ve been told.”
• “I’m 54 years old. My osteoarthritis is severe. I have been down for about 3 or 4 years. I was told that I needed a total knee replacement. I asked my rheumatologist about the knee gel. I didn’t know that he contacted my insurance company for approval. To my surprise, it was approved for both of my knees. On the 1st injection, I can get up again without assistance [1]. I have 2 more injections scheduled. I’m back outside, ya’ll.”

Supartz injections are known for their safety. They have shown promising results in both studies and after they’ve been sold to people. Here are some testimonials: 

• “As a plant mechanic, my knees were put under a lot of stress. Climbing ladders, stairs, kneeling, crouching, etc. I got my first injections in 2015. Three injections a week apart. It stopped the degeneration of my cartilage. I was getting them every six to eight months until I retired. Due to insurance changes, I haven’t had them in almost three years. In three months, I’ll have better insurance and cannot wait until I can get the injections. For me, they are a great benefit. Now that I’m not working, they will hopefully last much longer.”

 

Practical Considerations

Practical differences between Orthovisc vs Supartz include the number of injections typically used, treatment schedules, product formulation, and individual patient considerations. Orthovisc is a knee osteoarthritis treatment involving injecting hyaluronic acid into the joint. It aims to improve joint mobility and reduce pain.

• Orthovisc requires a series of 3-4 injections.
• Doctors give these injections one week apart.
• This process helps to restore synovial fluid in the knee, improving its natural functions.
• Before each injection, the area around the knee is cleaned to prevent infection.
• A local anesthetic may numb the knee, making the procedure more comfortable.
• The healthcare provider carefully injects Orthovisc directly into the knee joint space.
• After the injection, patients might need to rest their knees and avoid strenuous activities for 48 hours.
• Patients should immediately report any side effects, such as swelling or pain at the injection site, to their doctor.
• Follow-up appointments are essential to check progress and decide if more treatments are needed.
• The whole course aims to reduce joint pain and improve mobility over time with minimal risk factors involved.

Supartz is unique because it involves a series of injections designed to alleviate knee pain caused by osteoarthritis.

• Supartz is given as an injection directly into the knee joint.
• The treatment consists of one injection per week.
• Patients typically receive a total of 5 injections throughout treatment.
• Each injection contains highly purified sodium hyaluronate.
• The goal is to improve joint function and reduce pain.
• Medical professionals should monitor patient reactions after each injection.
• It’s crucial to maintain sterile techniques to prevent infection.
• Doctors may advise patients on activities to avoid post-injection for optimal results.
• Understanding patient history and potential allergies is essential before starting treatment.

Conclusion

The Orthovisc vs Supartz comparison shows that both are viscosupplementation options for knee osteoarthritis, but differences in formulation and treatment schedules may influence therapy selection. While they have similar mechanisms of action, their formulations and clinical effects may differ. Healthcare providers should consider the individual patient’s needs, treatment cost, and practical considerations when choosing between Orthovisc and Supartz to manage knee osteoarthritis.

FAQs

1. Can anyone get Orthovisc or Supartz, or is it just for some individuals?

These shots are mainly for people with knee arthritis who haven’t felt better with other treatments.

2. How fast do they work? Will I feel better tomorrow?

After getting these shots, feeling less knee pain might take a few weeks.

3. Do I need to return for more shots, or is one enough?

To see if it helps, you might need three to five shots of Supartz or just one shot of Orthovisc.

4. Is one better than the other at reducing the pain?

Both can lower knee pain, but your doctor will choose the best based on your needs.

Citations

[1] WebMD. “User Reviews for ORTHOVISC Intra-Articular.” WebMD, n.d., https://reviews.webmd.com/drugs/drugreview-81236-orthovisc-intra-articular.

[2] World Health Organization. “Osteoarthritis.” World Health Organization, 14 July 2023, https://www.who.int/news-room/fact-sheets/detail/osteoarthritis

[3] WebMD. “User Reviews for Supartz Intra-Articular.” WebMD, n.d., https://reviews.webmd.com/drugs/drugreview-21749-supartz-intra-articular